(291722), N. R., (3607649), M. X., (10930980), M. O. W., & (291723), P. J. T. (2021). Reversal of Insulin Resistance in Overweight and Obese Subjects by trans-Resveratrol and Hesperetin Combination—Link to Dysglycemia, Blood Pressure, Dyslipidemia, and Low-Grade Inflammation.
Chicago Style (17th ed.) Citation(291722), Naila Rabbani, Mingzhan Xue (3607649), Martin O. Weickert (10930980), and Paul J. Thornalley (291723). Reversal of Insulin Resistance in Overweight and Obese Subjects by Trans-Resveratrol and Hesperetin Combination—Link to Dysglycemia, Blood Pressure, Dyslipidemia, and Low-Grade Inflammation. 2021.
MLA (9th ed.) Citation(291722), Naila Rabbani, et al. Reversal of Insulin Resistance in Overweight and Obese Subjects by Trans-Resveratrol and Hesperetin Combination—Link to Dysglycemia, Blood Pressure, Dyslipidemia, and Low-Grade Inflammation. 2021.